Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Availability Heuristic

The Availability Heuristic

A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study.

Stroke·2026

Same author

Efficacy and Safety of NFL-101 as a Smoking Cessation Therapy: A Randomized Phase II Clinical Trial CESTO2.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025

Same author

Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.

PloS one·2024

Same author

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO<sup>®</sup> in Healthy Adults.

Neurology and therapy·2024

Same author

Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial.

The Lancet. Neurology·2024

Same author

Controlled human infection trials: Legitimacy and conditions of implementation in France.

Therapie·2023

Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026

Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026

Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026

Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026

Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026

Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 18, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

[Not Available].

Soizic Courcier¹, Claire Sibenaler², Monique Couderc³

¹Bristol-Myers-Squibb, Rueil-Malmaison, France.

|July 10, 2016

Summary

This summary is machine-generated.

France remains an attractive location for international clinical trials, participating in half of all global studies and ranking second in Europe for patient recruitment. The country shows high productivity in phase IIb and oncology research.

Keywords:

France competitiveness compétitivité entreprises du médicament international clinical research pharmaceutical companies recherche clinique internationale

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

Related Experiment Videos

Last Updated: Mar 18, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

Area of Science:

Clinical Research
Pharmaceutical Industry
Health Economics

Context:

A biennial survey assesses France's attractiveness for international clinical trials.
The 2006 survey was highly representative, including 20 companies (61% of the French market).
Data encompassed 352 international Phase II and III trials (2004-2005), 74 countries, 17,345 centers, and 137,989 patients.

Purpose:

To evaluate France's position and attractiveness for conducting international clinical trials.
To assess recruitment rates and productivity in clinical research within France.
To understand the impact of regulatory timelines, such as the 60-day Ethics Committee (CCPPRB) approval.

Summary:

France participates in 50% of all international clinical trials surveyed.
The country ranks second in Europe for patient recruitment per capita (0.19 patients/1000 inhabitants).
High productivity is noted in Phase IIb trials and oncology research.

Impact:

France demonstrates significant capacity and efficiency in hosting global clinical research.
The streamlined Ethics Committee approval process contributes to France's attractiveness.
Continued high performance in key therapeutic areas solidifies France's role in international drug development.